Stay updated on Flotetuzumab EAP in AML: Investigational Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.

Latest updates to the Flotetuzumab EAP in AML: Investigational Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRecord History now shows a new revision entry, v3.5.4, indicating an update to the study record's revision history. The previous entry, v3.5.3, is removed from the current history view.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page footer’s system revision/version indicator was updated from v3.5.0 to v3.5.3, reflecting a platform update with no change to the study’s record contents.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded Revision v3.4.3 to the study record history. Removed Revision v3.4.2.SummaryDifference0.1%

- Check105 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history and the previous revision (v3.4.1) was removed.SummaryDifference0.1%

- Check113 days agoChange DetectedA new revision entry (v3.4.1) was added to the study record history, replacing the prior v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Flotetuzumab EAP in AML: Investigational Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab EAP in AML: Investigational Clinical Trial page.